Related Experiment Videos

The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram

Chiharu Kawaguchi1, Yukihiro Takahashi, Yae Hanesaka

  • 1Division of Neonatal Intensive Care, Nara Medical University Hospital, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

Thrombosis and Haemostasis
|November 13, 2002
PubMed

We investigated the effects of addition of recombinant activated coagulation factor VII (rFVIIa) to coagulation factor-deficient plasma and whole blood, using thrombelastograms (TEGs). The addition of rFVIIa to factor II- or X-deficient plasma did not correct hemostatic parameters, whereas it produced partial responses in factor V-, VIII- or IX-deficient plasma and good responses in factor VII-, XI- or XII-deficient plasma. Furthermore, the addition of rFVIIa and platelets (30-100 x 10(3)/ micro l) to platelet-poor plasma produced marked corrections, producing TEGs similar to those of platelet-rich plasma. These results indicate that factors II and X are essential for the hemostatic effects of rFVIIa, and that factors V and VIII promote these effects. We believe that TEGs are, at present, one of the most useful tools for evaluating in vitro hemostatic effects of rFVIIa.

Related Concept Videos